By Nascent Biotech Posted November 25, 2019 In HAH 2020 CFP 2pp Leaflet-2 copy2019-11-252019-11-25http://www.nascentbiotech.com/wp-content/uploads/2015/06/nascent-logo-horiz-300.pngNascent Biotechhttp://www.nascentbiotech.com/wp-content/uploads/2015/06/nascent-logo-horiz-300.png200px200px 0 HAH 2020 CFP 2pp Leaflet-2 copy Recent PostsNascent Biotech Receives Notice of the Issuance of US Patent No.11,494,394Nascent Begins Enrollment of Final Patient Cohort to Complete Phase One Clinical ResearchNascent Biotech Completes Fourth Cohort in Phase 1 Human Trial for Primary and Metastatic Brain CancerNascent Biotech Receives Notice of Allowance from USPTO for Issuance of Additional Patent
